These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 12097388

  • 1. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.
    Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC.
    J Immunol; 2002 Jul 15; 169(2):847-55. PubMed ID: 12097388
    [Abstract] [Full Text] [Related]

  • 2. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
    Chawla-Sarkar M, Leaman DW, Borden EC.
    Clin Cancer Res; 2001 Jun 15; 7(6):1821-31. PubMed ID: 11410525
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 4. Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.
    Chawla-Sarkar M, Bauer JA, Lupica JA, Morrison BH, Tang Z, Oates RK, Almasan A, DiDonato JA, Borden EC, Lindner DJ.
    J Biol Chem; 2003 Oct 10; 278(41):39461-9. PubMed ID: 12881518
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein.
    Frese S, Brunner T, Gugger M, Uduehi A, Schmid RA.
    J Thorac Cardiovasc Surg; 2002 Jan 10; 123(1):168-74. PubMed ID: 11782771
    [Abstract] [Full Text] [Related]

  • 6. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP, Zisman A, Bonavida B.
    Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
    Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC.
    Cell Death Differ; 2004 Aug 01; 11(8):915-23. PubMed ID: 15118763
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 9. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.
    Leaman DW, Chawla-Sarkar M, Vyas K, Reheman M, Tamai K, Toji S, Borden EC.
    J Biol Chem; 2002 Aug 09; 277(32):28504-11. PubMed ID: 12029096
    [Abstract] [Full Text] [Related]

  • 10. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR, Ng CP, Gan XH, Schiller G, Bonavida B.
    Clin Cancer Res; 2001 Dec 09; 7(12):3874-83. PubMed ID: 11751478
    [Abstract] [Full Text] [Related]

  • 11. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
    Ng CP, Bonavida B.
    Mol Cancer Ther; 2002 Oct 09; 1(12):1051-8. PubMed ID: 12481428
    [Abstract] [Full Text] [Related]

  • 12. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).
    Ravi R, Bedi A.
    Cancer Res; 2002 Mar 15; 62(6):1583-7. PubMed ID: 11912124
    [Abstract] [Full Text] [Related]

  • 13. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 15; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 14. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.
    Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N.
    Am J Pathol; 2002 Aug 15; 161(2):643-54. PubMed ID: 12163389
    [Abstract] [Full Text] [Related]

  • 15. Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias.
    Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP.
    Expert Opin Investig Drugs; 2001 Aug 15; 10(8):1521-30. PubMed ID: 11772267
    [Abstract] [Full Text] [Related]

  • 16. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 17. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
    Reu FJ, Leaman DW, Maitra RR, Bae SI, Cherkassky L, Fox MW, Rempinski DR, Beaulieu N, MacLeod AR, Borden EC.
    Cancer Res; 2006 Mar 01; 66(5):2785-93. PubMed ID: 16510600
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
    Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM.
    Int J Cancer; 2002 Jun 01; 99(4):491-504. PubMed ID: 11992538
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P.
    Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775
    [Abstract] [Full Text] [Related]

  • 20. Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines.
    Siervo-Sassi RR, Marrangoni AM, Feng X, Naoumova N, Winans M, Edwards RP, Lokshin A.
    Cancer Lett; 2003 Feb 10; 190(1):61-72. PubMed ID: 12536078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.